It is an important point but we cant at the moment say anything about that, he said. That rose to more than 85% after the second dose. The numbers were very small and there was uncertainty over their significance, said the researchers. The study was not set up to look at any differences between the two. He said the numbers were consistent with a relatively constant protection of about 70% at that stage.
More than half of the participants in the study reported experiencing some type of side effects.
( z0 report :ARG0 ( z1 person :ARG1-of ( z2 include :ARG2 ( z3 person :ARG0-of ( z4 participate :ARG1 ( z5 study ) ) ) :ARG3 ( z6 more-than :op "1/2" ) ) ) :ARG1 ( z7 experience :ARG0 z1 :ARG1 ( z8 effect :mod ( z9 side ) :mod ( z10 type :mod ( z11 some ) ) ) ) )
(z0 / report-01
    :ARG0 (z1 / person
              :ARG1-of (z2 / include-91
                           :ARG2 (z3 / person
                                     :ARG0-of (z4 / participate-01
                                                  :ARG1 (z5 / study-01)))
                           :ARG3 (z6 / more-than
                                     :op1 "1/2")))
    :ARG1 (z7 / experience-01
              :ARG0 z1
              :ARG1 (z8 / effect-03
                        :mod (z9 / side)
                        :mod (z10 / type
                                  :mod (z11 / some)))))
More than half of the participants in the study reported experiencing some type of side effects .
z2 :ARG3 z6
z6 :op1 0
z1 :ARG1-of z2
z2 :ARG2 z3
z3 :ARG0-of z4
z4 :ARG1 z5
z0 :ARG0 z1
z0 :ARG1 z7
z7 :ARG0 z1
z10 :mod z11
z8 :mod z9
z8 :mod z10
z7 :ARG1 z8